ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,222.68
      0.16%
      US Tech 100
      17,650.00
      0.05%
      Dow Jones
      39,512.84
      0.32%
      Brent Oil
      82.585
      0.00%
      Bitcoin
      61,039.38
      0.40%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Centessa Pharmaceuticals PLC (CNTA)

      7. Centessa Pharmaceuticals PLC (CNTA) News

      CNTA Centessa Pharmaceuticals PLC

      8.97
      -0.58 (-6.07%)
      May 10 2024 - Closed
      Delayed by 15 minutes
      Company Name Stock Ticker Symbol Market Type
      Centessa Pharmaceuticals PLC CNTA NASDAQ Depository Receipt
        Price Change Change Percent Stock Price Last Traded
      Upgrade Icon
      -0.58 -6.07% 8.97 20:00:00
      Open Price Low Price High Price Close Price Prev Close
      9.57 8.83 9.68 8.97 9.55
      more quote information »

      Recent News

      Date Time Source Heading
      5/09/202408:01EDGAR2Form ARS - Annual Report to Security Holders
      5/09/202408:00EDGAR2Form DEF 14A - Other definitive proxy statements
      4/23/202421:36GLOBECentessa Pharmaceuticals Announces Pricing of $100 Million..
      4/23/202416:17GLOBECentessa Pharmaceuticals Announces $100 Million Proposed..
      4/22/202407:00GLOBECentessa Pharmaceuticals Announces Open IND for ORX750;..
      3/28/202416:28GLOBECentessa Pharmaceuticals Reports Business Highlights and..
      2/22/202408:00GLOBECentessa Pharmaceuticals to Participate in TD Cowen’s 44th..
      2/09/202407:12EDGAR2Form 8-K - Current report
      2/09/202407:00GLOBECentessa Pharmaceuticals to Present Additional 52-Weeks of..
      2/02/202417:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/02/202417:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/02/202417:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/02/202417:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/02/202417:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/01/202416:07EDGAR2Form 144 - Report of proposed sale of securities
      1/22/202408:00GLOBECentessa Pharmaceuticals to Participate in Upcoming Investor..
      1/09/202407:56EDGAR2Form 8-K - Current report
      1/02/202419:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/02/202419:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/02/202419:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/02/202419:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/02/202419:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      12/13/202308:00GLOBECentessa Pharmaceuticals to Present at the 42ⁿᵈ Annual J.P...
      12/11/202307:05EDGAR2Form 8-K - Current report
      12/10/202312:05GLOBECentessa Pharmaceuticals Announces New Data from an..
      11/27/202316:15GLOBEAnaptys Expands Immune Cell Modulator Pipeline with..
      11/13/202316:22EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
      11/13/202316:17EDGAR2Form 8-K - Current report
      11/13/202316:05GLOBECentessa Pharmaceuticals Reports Financial Results and..
      11/02/202309:09GLOBECentessa Pharmaceuticals to Present Additional 52-Weeks of..
      10/31/202308:00GLOBECentessa Pharmaceuticals Announces Dosing of First Subject..
      10/30/202308:00GLOBECentessa Pharmaceuticals to Participate in Upcoming Investor..
      10/25/202309:49EDGAR2Form 8-K - Current report
      10/25/202308:00GLOBECentessa Pharmaceuticals Announces Preclinical Data..
      10/03/202317:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      10/03/202316:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      10/03/202316:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      10/03/202316:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      10/03/202316:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      10/03/202308:00GLOBECentessa Pharmaceuticals Announces Additions to Senior..
      9/22/202316:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      9/20/202316:02EDGAR2Form 144 - Report of proposed sale of securities
      9/01/202316:31EDGAR2Form 144 - Report of proposed sale of securities
      8/31/202308:00GLOBECentessa Pharmaceuticals to Participate in the Morgan..
      8/23/202317:08GLOBECentessa Pharmaceuticals to Present Preclinical Data for..
      8/14/202307:18EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
      8/14/202307:06EDGAR2Form 8-K - Current report
      8/14/202307:00GLOBECentessa Pharmaceuticals Reports Financial Results and..
      8/01/202316:13EDGAR2Form 144 - Report of proposed sale of securities
      7/10/202317:00EDGAR2Form 8-K - Current report

      Your Recent History

      NASDAQ
      CNTA
      Centessa Pharmaceuticals
      LSE
      81RF
      Sandwell 2 'e'
      USOTC
      BRDLF
      Broadleaf (PK)
      AQSE
      OPG.GB
      Opg Power Ventures
      TSXV
      ICPH
      ICPEI
      BIBX
      MOTETH
      Olympus Labs
      NASDAQ
      ARQT
      Arcutis Biotherapeutics
      Delayed Upgrade Clock